Anti-Species Immunoglobulins Vs Guinea Pig Immunoglobulins: Description, Application and Production
Anti-species immunoglobulins against guinea pig immunoglobulins is a medical product that is used to treat diseases caused by the influenza virus in humans. This drug is produced in Russia by the company NII EM, which is an enterprise for the production of bacterial preparations named after. N.F. Gamaleya.
The international name of this drug is anti-species immunoglobulins against guinea pig immunoglobulins. It belongs to the pharmacological group of immunoglobulins, which are used to treat infectious diseases.
The drug Anti-species immunoglobulins against guinea pig immunoglobulins is presented in diagnostic dosage forms, fluorescent dry powders, lyophilisates and ampoules. It contains antibodies against the influenza virus that have been isolated from the blood of immune donors.
The drug is used to prevent and treat influenza, as well as to treat complications associated with this disease. It is recommended for use in patients who cannot receive influenza vaccination due to allergic reactions or other medical contraindications.
The drug Anti-species immunoglobulins against guinea pig immunoglobulins is a safe and effective treatment for influenza. However, like any other medicine, it can cause unwanted effects. Therefore, before using the drug, you must consult your doctor and strictly follow the instructions for use.
In conclusion, it can be noted that the drug Anti-species immunoglobulins against guinea pig immunoglobulins is an important tool for the prevention and treatment of influenza. Due to the high quality of production and the effectiveness of the drug, it is widely used in medical practice and helps maintain people's health.